Top Markets
Coin of the day
BNC Korea Co., Ltd. BNC Korea Co., Ltd.

BNC Korea Co., Ltd.

256840
株式のランク #21183
Based in South Korea, BNC Korea Co., Ltd. focuses on the research, development,... Based in South Korea, BNC Korea Co., Ltd. focuses on the research, development, manufacturing, and distribution of various biomaterials. The company's diverse product range features hyaluronic acid (HA) and skin booster fillers, including brand names like Cutegel, Cutegel Lidocaine, FLORE Lidocaine, ChungA-an, CUTEGEL-M, Cutegel Hydro, S-DNA, and H-DNA, all designed for the temporary reduction of facial wrinkles through physical restoration. Beyond aesthetic products, BNC Korea also manufactures Hibarry, a specialized dressing for deep-cavity wounds, which helps mitigate spinal cord adhesion during surgery. Another key medical product is GENTA Q, a white collagen sponge created to protect wounds by preventing contamination. Additionally, the company offers a line of beauty solutions, encompassing face mask gels, mild cleansing foams, and brightening peeling gels. With a significant international presence, BNC Korea exports its products to 45 countries. The firm was founded in 2007 and is headquartered in Daegu, South Korea.
株価
$1.65
最終同期: 2026-08-21
時価総額
$113.03M
変化(1日)
-3.63%
変化(1年)
-52.19%
KR
取引 BNC Korea Co., Ltd. (256840)

カテゴリー

BNC Korea Co., Ltd.(256840)の利益
2026 時点の利益 TTM: 0
BNC Korea Co., Ltd. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
BNC Korea Co., Ltd. の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。